Dompé U.S. Inc. faces regulatory scrutiny after a $32 million settlement due to Anti-Kickback violations. Learn the implications for insurance compliance professionals.

Discover the impact of Medicare's $274 negotiated Ozempic price on beneficiaries and Part D plans. Know your options during Open Enrollment!

Explore the key impact of generic drugs and biosimilars on reducing prescription costs in the U.S. healthcare system, including legislative efforts and market dynamics.